Actively Recruiting
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
Led by Montefiore Medical Center · Updated on 2025-05-22
10
Participants Needed
1
Research Sites
133 weeks
Total Duration
On this page
Sponsors
M
Montefiore Medical Center
Lead Sponsor
S
Sciton
Collaborating Sponsor
AI-Summary
What this Trial Is About
Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.
CONDITIONS
Official Title
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males and females aged 18 years or older seeking treatment for hair loss
- Voluntarily signed informed consent form
- Diagnosis of biopsy-proven androgenetic alopecia or scarring alopecia with hair loss documented over the past 6 months
- Stable hair loss treatment regimen with plateaued results for at least 3 months
- Able to understand and provide written informed consent
- Healthy non-smoker agreeing not to change daily hair treatment during the study
- Willing to comply with treatment protocol and follow-up schedule
- Agree not to undergo other treatments in the scalp areas during follow-up period
You will not qualify if you...
- Unable to provide consent for the study
- Presence of other alopecia types like alopecia areata
- Use of minoxidil or 5-alpha reductase inhibitors within 3 months before screening
- History of intralesional steroid injections to scalp in last 12 months
- Pregnant women
- Medical conditions increasing risk of photosensitivity reactions
- Surgical procedures in treatment area within past 12 months or major surgery in last 6 months
- Allergy or prior reaction to lidocaine
- History of immunosuppression or immune deficiency disorders including AIDS or HIV
- Use of immunosuppressive medications or biologics within 6 months prior and during study
- Use of Accutane or systemic retinoids in past 12 months
- Smoking or vaping in past 12 months
- History of uncontrolled hyperlipidemia, diabetes, hepatitis, or bleeding disorders
- History of major depressive or endocrine disorders such as hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Montefiore Einstein Advanced Care
Elmsford, New York, United States, 10523
Actively Recruiting
Research Team
A
Anika Jallorina, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here